Call for vigilance on bleeding risk

AN INCREASED risk of abnormal bleeding for patients taking concomitant antidepressants and NSAIDs has prompted specialists to call for extra vigilance and a clearer communication of the risks.

Brain haemorrhage

A nationwide study of four million Koreans finds that hospitalisation for intracranial haemorrhage is 60% more likely in patients taking both medications, compared with those taking antidepressants alone.

Professor Philip Mitchell, head of the school of psychiatry at the University of NSW, says it is an important study highlighting the potentially serious bleeding risks